Table 1. Morphological variables and cardiac function in vivo evaluated by Echocardiogram. C: control group; A: açai group; D: doxorubicin group; DA: doxorubicin + açai group; HR: heart rate; LVSD: left ventricle (LV) systolic diameter; LVDD: LV diastolic diameter; PW: diastolic posterior wall thickness; IVS: diastolic interventricular septum thickness; LA: left atrium diameter; FS: LV fractional shortening; E: peak velocity of early ventricular filling; A: peak velocity of transmitral flow during atrial contraction; IVRTc: isovolumetric relaxation time corrected by HR. p value: two-way ANOVA, except ^@, which were analyzed by t-test or Mann-Whitney test (in these cases, p values were considered significant when <0.008); pi: p value for doxorubicin vs açai interaction; *different from C group; ^&different from D group